ArticleFrontiers in neurology2024

Long-term safety of OnabotulinumtoxinA treatment in chronic migraine patients: a five-year retrospective study.

María Pilar Navarro-Pérez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.